Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.

ABSTRACT:

Importance

Pancreatic ductal adenocarcinoma (PDAC) has a higher incidence and worse outcomes among black patients than white patients, potentially owing to a combination of socioeconomic, biological, and treatment differences. The role that these differences play remains unknown.

Objectives

To determine the level of survival disparity between black and white patients in a modern PDAC cohort and whether treatment inequity is associated with such a disparity.

Design, setting, and participants

This cohort study used data on 278 936 patients with PDAC with database-defined race from the National Cancer Database from January 1, 2004, to December 31, 2015. The median follow-up for censored patients was 24 months. The National Cancer Database, comprising academic and communi

SUBMITTER: Heller DR 

PROVIDER: S-EPMC6902102 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature